CINECA IRIS Institutional Research Information System

FATTORE, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 520
SA - Sud America 255
NA - Nord America 164
EU - Europa 121
AF - Africa 19
Totale 1.079
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 202
VN - Vietnam 152
SG - Singapore 141
US - Stati Uniti d'America 138
CN - Cina 90
DE - Germania 40
KR - Corea 37
AR - Argentina 30
HK - Hong Kong 26
IT - Italia 25
FR - Francia 23
ID - Indonesia 22
BD - Bangladesh 21
MX - Messico 14
EC - Ecuador 11
IN - India 9
PL - Polonia 8
CA - Canada 7
ZA - Sudafrica 7
IQ - Iraq 6
PY - Paraguay 5
ES - Italia 4
RU - Federazione Russa 4
TN - Tunisia 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CL - Cile 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
IE - Irlanda 2
JP - Giappone 2
MA - Marocco 2
NL - Olanda 2
SY - Repubblica araba siriana 2
TR - Turchia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
FI - Finlandia 1
GA - Gabon 1
GB - Regno Unito 1
GE - Georgia 1
GR - Grecia 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
UY - Uruguay 1
Totale 1.079
Salva come PNG Salva come JPEG
Città #
Ho Chi Minh City 53
Frankfurt am Main 38
Seoul 37
Singapore 36
Ashburn 35
San Jose 28
Hanoi 27
Hong Kong 26
Beijing 20
Mexico City 13
São Paulo 11
Haiphong 9
New York 9
Guayaquil 8
Biên Hòa 6
Da Nang 6
Dallas 6
Hải Dương 5
Porto Alegre 5
Rome 5
Sorocaba 5
Warsaw 5
Duque de Caxias 4
Ha Long 4
Jakarta 4
Los Angeles 4
Ninh Bình 4
Phoenix 4
Roubaix 4
São Bernardo do Campo 4
Belo Horizonte 3
Blumenau 3
Brasília 3
Bắc Giang 3
Catanduva 3
Chennai 3
Council Bluffs 3
Curitiba 3
Des Moines 3
Guarulhos 3
Joinville 3
Rio de Janeiro 3
Teresina 3
Thái Bình 3
Tunis 3
Wroclaw 3
Asunción 2
Atibaia 2
Can Tho 2
Cape Town 2
Catalão 2
Chapecó 2
Chicago 2
Ciudad del Este 2
Corrientes 2
Decatur 2
Dubai 2
Dublin 2
Fortaleza 2
Hortolândia 2
Johannesburg 2
João Pessoa 2
Lehigh Acres 2
Limburg an der Lahn 2
Madrid 2
Milan 2
Montreal 2
Osasco 2
Phủ Lý 2
Quito 2
Rosario 2
Salvador 2
Santa Maria 2
Surakarta 2
Suzano 2
São Leopoldo 2
Tashkent 2
Tirana 2
Tokyo 2
Toronto 2
Addis Ababa 1
Al Qaţīf 1
Al Qāhirah al Jadīdah 1
Al'met'yevsk 1
Alausí 1
Albuquerque 1
Amsterdam 1
Andradas 1
Aragarças 1
Araguaína 1
Arapiraca 1
Araranguá 1
Araraquara 1
Araçatuba 1
Armyansk 1
Astana 1
Athens 1
Atlanta 1
Azul 1
Açailândia 1
Totale 561
Salva come PNG Salva come JPEG
Nome #
ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma. Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin 48
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance 43
C-Src recruitment is Involved in c-MET-mediated malignant behaviour of NT2D1 non-seminoma cells 42
CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions 37
Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma 37
Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients 37
MirRNAs for treatment and in vitro diagnosis of drug resistant tumors 36
The new world of RNA diagnostics and therapeutics 34
miR-579-3p controls melanoma progression and resistance to target therapy 34
ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors 34
Cancer stem cells and the slow cycling phenotype. how to cut the gordian knot driving resistance to therapy in melanoma 34
Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies 34
In Vitro Biophysical and Biological Characterization of Lipid Nanoparticles Co-Encapsulating Oncosuppressors miR-199b-5p and miR-204-5p as Potentiators of Target Therapy in Metastatic Melanoma 33
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma 32
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits non-small cell lung cancer 32
Monoclonal antibody-induced ErbB3 receptor internalization and degradation inhibits growth and migration of human melanoma cells 31
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma 30
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors 30
microRNA-378a-5p iS a Novel Positive Regulator of Melanoma Progression 30
Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma 29
Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization 29
Toxicity of aflatoxin B1 towards the vitamin D receptor (VDR) 29
Drug tolerance to target therapy in melanoma revealed at single cell level. What next? 29
Method for predicting the development of resistance to BRAF inhibiting drugs, alone or in combination with MEK inhibiting drugs, in an anti-tumour treatment 28
The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma 27
MicroRNAs in melanoma development and resistance to target therapy 26
Self-assembling nanoparticles for miRNA delivery towards precision medicine against melanoma 26
TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung 24
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application 24
Role of WT1-ZNF224 interaction in the expression of apoptosis-regulating genes 24
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors 23
The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma 21
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin 20
Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma 20
Selective targeting of point-mutated KRAS through artificial microRNAs 19
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma 17
Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma 16
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and Application 15
PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models 3
miRNA-driven cancer cell plasticity, tolerance and therapy resistance: lessons from melanoma 2
Totale 1.119
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202541 0 0 0 0 0 0 0 0 0 0 0 41
2025/20261.078 89 24 187 270 104 51 17 71 92 105 58 10
Totale 1.119